BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12235165)

  • 1. Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells.
    Holnthoner W; Pillinger M; Groger M; Wolff K; Ashton AW; Albanese C; Neumeister P; Pestell RG; Petzelbauer P
    J Biol Chem; 2002 Nov; 277(48):45847-53. PubMed ID: 12235165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.
    Albanese C; Wu K; D'Amico M; Jarrett C; Joyce D; Hughes J; Hulit J; Sakamaki T; Fu M; Ben-Ze'ev A; Bromberg JF; Lamberti C; Verma U; Gaynor RB; Byers SW; Pestell RG
    Mol Biol Cell; 2003 Feb; 14(2):585-99. PubMed ID: 12589056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.
    Schmitt-Graeff A; Ertelt-Heitzmann V; Allgaier HP; Olschewski M; Nitschke R; Haxelmans S; Koelble K; Behrens J; Blum HE
    Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
    Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
    Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional screen in human cells identifies UBF2 as an RNA polymerase II transcription factor that enhances the beta-catenin signaling pathway.
    Grueneberg DA; Pablo L; Hu KQ; August P; Weng Z; Papkoff J
    Mol Cell Biol; 2003 Jun; 23(11):3936-50. PubMed ID: 12748295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway.
    Debiais F; Lefèvre G; Lemonnier J; Le Mée S; Lasmoles F; Mascarelli F; Marie PJ
    Exp Cell Res; 2004 Jul; 297(1):235-46. PubMed ID: 15194439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
    Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
    J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter.
    Filali M; Cheng N; Abbott D; Leontiev V; Engelhardt JF
    J Biol Chem; 2002 Sep; 277(36):33398-410. PubMed ID: 12052822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone.
    Natsume H; Sasaki S; Kitagawa M; Kashiwabara Y; Matsushita A; Nakano K; Nishiyama K; Nagayama K; Misawa H; Masuda H; Nakamura H
    Biochem Biophys Res Commun; 2003 Sep; 309(2):408-13. PubMed ID: 12951064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S; Bapat B
    Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
    Staal FJ; Burgering BM; van de Wetering M; Clevers HC
    Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental expression of Wnt signaling factors in mouse brain.
    Coyle-Rink J; Del Valle L; Sweet T; Khalili K; Amini S
    Cancer Biol Ther; 2002; 1(6):640-5. PubMed ID: 12642687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.
    Shtutman M; Zhurinsky J; Simcha I; Albanese C; D'Amico M; Pestell R; Ben-Ze'ev A
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5522-7. PubMed ID: 10318916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
    Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
    Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling through beta-catenin and Lef/Tcf.
    Novak A; Dedhar S
    Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
    Ishitani T; Ninomiya-Tsuji J; Matsumoto K
    Mol Cell Biol; 2003 Feb; 23(4):1379-89. PubMed ID: 12556497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
    Tetsu O; McCormick F
    Nature; 1999 Apr; 398(6726):422-6. PubMed ID: 10201372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
    Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
    Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.
    Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Cherqui G; Perret C; Capeau J
    Oncogene; 2001 Jan; 20(2):252-9. PubMed ID: 11313952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor-mediated T-cell factor/lymphoid enhancer factor transcriptional activity is essential but not sufficient for cell cycle progression in nontransformed mammary epithelial cells.
    Graham NA; Asthagiri AR
    J Biol Chem; 2004 May; 279(22):23517-24. PubMed ID: 15026412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.